stockportfolio.pro
Cardinal Health, Inc. (CAH)
Healthcare · Medical Distribution · NYSE
Cardinal Health, Inc. revenue & earnings — last 10 fiscal years
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $121.55B | $129.98B | $136.81B | $145.53B | $152.92B | $162.47B | $181.36B | $205.01B | $226.83B | $222.58B |
| Gross profit | $6.54B | $6.54B | $7.18B | $6.83B | $6.87B | $6.78B | $6.48B | $6.87B | $7.41B | $8.17B |
| Net income | $1.43B | $1.29B | $256.00M | $1.36B | $-3.70B | $611.00M | $-933.00M | $261.00M | $852.00M | $1.56B |
| Net margin | 1.2% | 1.0% | 0.2% | 0.9% | -2.4% | 0.4% | -0.5% | 0.1% | 0.4% | 0.7% |
Source: Cardinal Health, Inc. SEC filings (10-K). 18 years of history available in the interactive view.
What growth is priced into CAH stock?
At today's market cap of $49.81B, Cardinal Health, Inc. is priced for free-cash-flow growth of about 11.8% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.85B from the FY ending 2025-06-30). For comparison, free cash flow actually grew 3.1%/yr over the last five fiscal years and revenue 7.8%/yr, computed from its SEC filings. This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 18 years of Cardinal Health, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track CAH in your portfolio →
Cardinal Health, Inc. financial history by metric
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Cardinal Health, Inc. — frequently asked questions
What is Cardinal Health, Inc.'s revenue?
Cardinal Health, Inc. (CAH) reported revenue of $222.58B for fiscal year 2025, down 1.9% from the prior year, according to its SEC filings.
Is Cardinal Health, Inc. profitable?
Yes. CAH earned net income of $1.56B in fiscal 2025, a net margin of 0.7%.
What is CAH's P/E ratio?
Cardinal Health, Inc. trades at a price-to-earnings ratio of about 32.5 based on the latest data in our nightly-refreshed cache.
How fast is Cardinal Health, Inc. growing?
CAH's revenue grew at roughly 7.8% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Cardinal Health, Inc. have?
As of fiscal year 2025, CAH carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Cardinal Health, Inc.'s gross margin?
CAH's gross margin was 3.7% in fiscal 2025 — gross profit of $8.17B on revenue of $222.58B.
What is Cardinal Health, Inc.'s market cap?
Cardinal Health, Inc. (CAH) has a market capitalization of about $49.81B, based on the latest data in our nightly-refreshed cache.
When does Cardinal Health, Inc.'s fiscal year end?
CAH's fiscal year ends in June. Its most recent annual filing covers the fiscal year ending 2025-06-30.
What growth is priced into CAH stock?
At today's market cap of $49.81B, Cardinal Health, Inc. is priced for free-cash-flow growth of about 11.8% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $1.85B from the FY ending 2025-06-30). For comparison, free cash flow actually grew 3.1%/yr over the last five fiscal years and revenue 7.8%/yr, computed from its SEC filings.
Where does this data come from?
All figures are computed from Cardinal Health, Inc.'s official SEC filings (10-K and 10-Q), covering 18 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.